Data through FY2026 Q3 (Jun 30, 2026)
Mylan Pharmaceuticals, Inc.
Company profile for Mylan Pharmaceuticals, Inc. covers 7 filings across the reporting window. FY2026 certified median offer: $83,801.
- FY2026 certified median
- $83,801
- Total filings
- 7
- FY2026 25th–75th percentile
- $83,801–$83,801
- Top job title
- Scientist
| Fiscal year | Filings | Median | 25th percentile | 75th percentile |
|---|---|---|---|---|
| FY2024 | 3 | $86,320 | $85,390 | $86,320 |
| FY2025 | 3 | $89,294 | $89,235 | $89,354 |
| FY2026 (Q1–Q3) | 1 | $83,801 | $83,801 | $83,801 |
FY2026 is partial (*). Its filing totals are not comparable to a full fiscal year.
Median offer by fiscal year
Top titles
- Scientist6 filings
- Senior Analyst NA FP&A1 filings
Top cities
- Morgantown6 filings
- Dallas1 filings